Atlas Trials

Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis

Clinical trial NCT01093885 · COMPLETED

Trial details

NCT number
NCT01093885
Sponsor
University of Pennsylvania
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Systemic SclerosisScleroderma
Start date
2010-02-01
Primary completion
2016-07-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.